Citation: | HOU Hui, ZHU Yinxing, WANG Taiyu, ZHANG Yi, LIU Zhipeng. Efficacy of support vector machine model constructed based on dual-parameter MRI radiomics in predicting the expression of human epidermal growth factor receptor-2 and hormone receptor in breast cancer patients[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 7-13. DOI: 10.7619/jcmp.20233503 |
To construct a support vector machine (SVM) model based on magnetic resonance imaging (MRI) T2WI turbo inversion recovery magnitude (TIRM) and diffusion-weighted imaging (DWI) sequences, and evaluate its predictive performance for expression levels of human epidermal growth factor receptor-2 (HER-2) and hormone receptor (HR) in breast cancer.
A total of 128 breast cancer lesions underwent breast MRI before surgery or treatment were collected, and were grouped according to immunohistochemical (IHC) method or in situ fluorescence hybridization (FISH) results. ITK-SNAP software was used to outline the three-dimensional volume region of interest (VOI) on magnetic resonance TIRM and DWI sequence images, and Pyradiomics program was introduced to extract the image omics features. After normalization of the data, a recursive feature elimination method based on support vector machine-recursive feature elimination (SVM-RFE) was used to filter the features. A total of 108 cases were divided into training group and verification group according to 8∶2 ratio by random stratified sampling method, and the other 20 cases were used as external test group. SVM machine learning classifier was used to construct the image omics model. Receiver operating characteristic (ROC) curve was used to evaluate the prediction efficiency of the model. DeLong test was used to evaluate the area under the curve (AUC) of each image omics model. SHAP algorithm was used for visual analysis, and the most contributing prediction features were screened.
The prediction efficiency of the combined model (training group AUC=0.94, verification group AUC=0.90) for HER-2 was higher than that of TIRM model(training group AUC=0.85, verification group AUC=0.80) and single DWI model(training group AUC=0.88, verification group AUC=0.66). The AUC of combined model in the external test group was 0.89. The feature contribution of DWI sequence obtained by SHAP algorithm was great. The image omics model based on the combination of TIRM and DWI sequence features (training group AUC=0.96, verification group AUC=0.88) and the single DWI sequence features (training group AUC=0.92, verification group AUC=0.86) was better than the model based on the single TIRM sequence features (training group AUC=0.84, verification group AUC=0.68) in HR prediction. The external test group proved that the combined model had good predictive efficiency, with an AUC of 0.90. The feature contribution of TIRM sequence obtained by SHAP algorithm was great.
The imaging omics model constructed based on the combined features of TIRM and DWI sequences in magnetic resonance imaging has good predictive efficacy for HER-2 level, and has great potential in predicting HR expression, which can provide a basis for the formulation of personalized treatment for breast cancer patients.
[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
[2] |
王海丽. 多参数MRI影像组学融合模型在预测HER-2 2+乳腺癌及不同激素受体状态下HER-2阳性乳腺癌中的应用价值[D]. 济南: 山东大学, 2021.
|
[3] |
REINERT T, GONÇALVES R, BINES J. Implications of ESR1 mutations in hormone receptor-positive breast cancer[J]. Curr Treat Options Oncol, 2018, 19(5): 24. doi: 10.1007/s11864-018-0542-0
|
[4] |
叶欣华, 熊戴群, 李金高. 西达本胺联合长春瑞滨软胶囊治疗HR阳性、HER-2阴性晚期乳腺癌的临床研究[J]. 实用癌症杂志, 2022, 37(12): 2070-2073. doi: 10.3969/j.issn.1001-5930.2022.12.041
|
[5] |
CANTINI L, PISTELLI M, MERLONI F, et al. Body mass index and hormone receptor status influence recurrence risk in HER2-positive early breast cancer patients[J]. Clin Breast Cancer, 2020, 20(1): e89-e98. doi: 10.1016/j.clbc.2019.06.008
|
[6] |
代婷, 苏桐, 王锐, 等. DCE-MRI影像特征对乳腺癌激素受体、HER-2及三阴性乳腺癌的预测价值[J]. 磁共振成像, 2023, 14(4): 57-67. https://www.cnki.com.cn/Article/CJFDTOTAL-CGZC202304011.htm
|
[7] |
LIANG X H, YU X Y, GAO T H. Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis[J]. Eur J Radiol, 2022, 150: 110247. doi: 10.1016/j.ejrad.2022.110247
|
[8] |
陈文静, 牟伟, 张文馨, 等. 平扫T2脂肪抑制序列图像纹理可提高诊断乳腺良恶性结节的准确率[J]. 分子影像学杂志, 2019, 42(4): 453-456. https://www.cnki.com.cn/Article/CJFDTOTAL-FZYX201904007.htm
|
[9] |
王振东, 李悦, 申炳俊, 等. 基于迁移学习的乳腺肿瘤组织病理图像分类研究[J]. 长春理工大学学报: 自然科学版, 2023, 46(5): 130-136. https://www.cnki.com.cn/Article/CJFDTOTAL-CGJM202305018.htm
|
[10] |
张斌伟, 苟思琪, 程钲益, 等. 乳腺癌患者血清PCSK9、Tracp5b及MUC1表达水平及其与肿瘤病理特征的相关性分析[J]. 检验医学与临床, 2023, 20(9): 1235-1239. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202309013.htm
|
[11] |
郑洁, 开震天, 夏超然, 等. 基于GEO及TCGA数据库建立乳腺癌他莫昔芬耐药相关预后模型[J]. 检验医学与临床, 2022, 19(23): 3227-3230. doi: 10.3969/j.issn.1672-9455.2022.23.016
|
[12] |
张维, 龙松权, 唐瑞骏. 不同分子分型乳腺癌血清CYFRA21-1、HCY和CA15-3的表达差异及与术后复发、转移的关系[J]. 检验医学与临床, 2023, 20(12): 1686-1689. doi: 10.3969/j.issn.1672-9455.2023.12.005
|
[13] |
BALTZER P, MANN R M, ⅡMA M, et al. Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group[J]. Eur Radiol, 2020, 30(3): 1436-1450. doi: 10.1007/s00330-019-06510-3
|
[14] |
FAN M, LIU Z H, XU M S, et al. Generative adversarial network-based super-resolution of diffusion-weighted imaging: application to tumour radiomics in breast cancer[J]. NMR Biomed, 2020, 33(8): e4345. doi: 10.1002/nbm.4345
|
[15] |
NEMETH A, CHAUDET P, LEPORQ B, et al. Multicontrast MRI-based radiomics for the prediction of pathological complete response to neoadjuvant chemotherapy in patients with early triple negative breast cancer[J]. MAGMA, 2021, 34(6): 833-844. doi: 10.1007/s10334-021-00941-0
|
[16] |
徐丽娜, 唐竹晓, 李双标, 等. 基于DWI和DCE-MRI的影像特征对四种不同分子亚型乳腺癌的诊断价值探讨[J]. 现代肿瘤医学, 2021, 29(1): 116-120. https://www.cnki.com.cn/Article/CJFDTOTAL-SXZL202101026.htm
|
[17] |
ZHANG S H, WANG X L, YANG Z, et al. Intra- and peritumoral radiomics model based on early DCE-MRI for preoperative prediction of molecular subtypes in invasive ductal breast carcinoma: a multitask machine learning study[J]. Front Oncol, 2022, 12: 905551. doi: 10.3389/fonc.2022.905551
|
[18] |
HUANG Y H, WEI L H, HU Y L, et al. Multi-parametric MRI-based radiomics models for predicting molecular subtype and androgen receptor expression in breast cancer[J]. Front Oncol, 2021, 11: 706733. doi: 10.3389/fonc.2021.706733
|
[19] |
LA FORGIA D, FANIZZI A, CAMPOBASSO F, et al. Radiomic analysis in contrast-enhanced spectral mammography for predicting breast cancer histological outcome[J]. Diagnostics, 2020, 10(9): 708. doi: 10.3390/diagnostics10090708
|
[20] |
WU Q X, WANG S, CHEN X, et al. Radiomics analysis of magnetic resonance imaging improves diagnostic performance of lymph node metastasis in patients with cervical cancer[J]. Radiother Oncol, 2019, 138: 141-148. doi: 10.1016/j.radonc.2019.04.035
|
[21] |
CHADDAD A, DANIEL P, NIAZI T. Radiomics evaluation of histological heterogeneity using multiscale textures derived from 3D wavelet transformation of multispectral images[J]. Front Oncol, 2018, 8: 96. doi: 10.3389/fonc.2018.00096
|